Diabetes Infection Risk Study Published
Analysis based on 8 articles · First reported Jun 06, 2026 · Last updated Jun 09, 2026
The study's findings could lead to increased demand for infection prevention products, diagnostic tools, and treatments for diabetic patients, benefiting pharmaceutical and medical device companies. Healthcare providers and insurers may face pressure to adapt guidelines and coverage for diabetes care to include more robust infection management strategies.
A major study led by 'St George s, University of London' and published in 'Diabetes (journal)' revealed that people with type 1 diabetes, type 2 diabetes, and prediabetes face significantly higher risks of infection, hospitalization, and death due to infections. 'Julia Critchley', the lead researcher, emphasized that infections are a 'health hazard' often overlooked in current clinical guidelines. The study, funded by the 'United Kingdom — National Institute for Health and Care Research', analyzed over 800,000 individuals in the 'United Kingdom' over five years. Findings showed type 1 diabetics had an 81% higher risk of primary care infections and a 337% higher risk of hospitalization. For type 2 diabetics, these risks were 51% and 91%, respectively, and for prediabetics, 35% and 33%. Infections were identified as the third most common underlying cause of death in type 2 diabetes, after cardiovascular disease and cancer. Researchers are advocating for infection prevention and management to be integrated into diabetes guidelines globally, including in the 'United Kingdom', 'Europe', and the 'United States'.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard